rxstat › Shortages › Perindopril Erbumine

Perindopril Erbumine (Coversyl) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Nov 5, 2026

Some Perindopril Erbumine products are in shortage in Canada (2 of 25 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 30, 2026.

An ACE inhibitor used to lower blood pressure and treat heart conditions such as heart failure.

Products affected
2 / 25
In shortage since
Jun 9, 2026
Est. full return
Nov 30, 2026
Reports on file
82
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
AURO-PERINDOPRIL
8MG · TABLET · AURO PHARMA INC
DIN 02459833 · since Sep 24, 2026, est. end Nov 30, 2026 · Demand increase for the drug.
Active shortage
AURO-PERINDOPRIL
2MG · TABLET · AURO PHARMA INC
DIN 02459817 · since Jun 9, 2026, est. end Nov 13, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PERINDOPRIL
8MG · TABLET · APOTEX INC
DIN 02289296 · ended May 7, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PERINDOPRIL
8MG · TABLET · APOTEX INC
DIN 02289296 · ended May 7, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PERINDOPRIL
2MG · TABLET · APOTEX INC
DIN 02289261 · ended Jun 18, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PERINDOPRIL
4MG · TABLET · APOTEX INC
DIN 02289288 · ended Jun 18, 2026 · Disruption of the manufacture of the drug.
Resolved
AURO-PERINDOPRIL
4MG · TABLET · AURO PHARMA INC
DIN 02459825 · ended Oct 26, 2026 · Disruption of the manufacture of the drug.
Resolved
COVERSYL
4MG · TABLET · SERVIER CANADA INC
DIN 02123282 · ended Oct 23, 2026 · Delay in shipping of the drug.
Resolved
PERINDOPRIL ERBUMINE
8MG · TABLET · SANIS HEALTH INC
DIN 02481650 · ended Sep 14, 2026 · Disruption of the manufacture of the drug.
Resolved
COVERSYL
8MG · TABLET · SERVIER CANADA INC
DIN 02246624 · ended Aug 7, 2026 · Delay in shipping of the drug.
Resolved
APO-PERINDOPRIL
2MG · TABLET · APOTEX INC
DIN 02289261 · ended Jun 3, 2026 · Disruption of the manufacture of the drug.
Resolved
COVERSYL
4MG · TABLET · SERVIER CANADA INC
DIN 02123282 · ended Apr 29, 2026 · Delay in shipping of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Perindopril Erbumine is currently affected by 2 active shortage reports filed with Health Canada by AURO PHARMA INC.

The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Perindopril Erbumine is classified under “ACE INHIBITORS, PLAIN” (ATC C09AA).

Recent changes

Common questions

What is Perindopril Erbumine used for?

An ACE inhibitor used to lower blood pressure and treat heart conditions such as heart failure.

When will Perindopril Erbumine be back in stock in Canada?

The latest manufacturer estimate is Nov 30, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Perindopril Erbumine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (ace inhibitors, plain)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Benazepril (Lotensin) No current shortage Enalapril (Vasotec) No current shortage Enalaprilat No current shortage Fosinopril No current shortage Captopril Partial shortage 4 of 9 reported products affected Cilazapril (Inhibace) Partial shortage 1 of 13 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.